| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 31, 2011Medtronic Expands Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Aug 31, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held companies, PEAK Surgical, Inc. and Salient...
-
Aug 28, 2011
PARIS, Aug 28, 2011 (BUSINESS WIRE) -- New clinical data presented today at the European Society of Cardiology Congress 2011 demonstrate positive long-term performance for the CoreValve(R)...
-
Aug 25, 2011
MINNEAPOLIS, Aug 25, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.2425 per share of the Company's common stock. The dividend is...
-
Aug 24, 2011ReadyLink 12-Lead ECG Enables Rural EMS Providers to Expand Regional STEMI Systems
REDMOND, Wash., Aug 24, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), today announced...
-
Aug 23, 2011Revenue of $4 Billion Driven by International Growth of 7% on a Constant Currency Basis; 19% as Reported
MINNEAPOLIS, Aug 23, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011. The Company...
-
Aug 20, 2011
MEMPHIS, Tenn., Aug 22, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced cervical disc recipient Doug McConnell successfully completed his swim across the English Channel today. McConnell,...
-
Aug 18, 2011New Offering Provides Therapy Option to Previously Unserved Patients with Larger Aortic Valves
MINNEAPOLIS, Aug 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for its 31mm Medtronic CoreValve(R) System, the only...
-
Aug 15, 2011InterStim Therapy for Bowel Control Recently Approved by the U.S. FDA
MINNEAPOLIS, Aug 15, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using...
-
Aug 12, 2011
MINNEAPOLIS, Aug 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2012 on Tuesday, August 23, 2011....
-
Aug 5, 2011
MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
-
Aug 3, 2011First of its Kind Post-Review Website to Provide Scientific Access to Full Clinical Data
MINNEAPOLIS, Aug 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. [NYSE: MDT] announced today that it has provided a grant to Yale University to conduct two fully independent, third-party systematic...
-
Aug 1, 2011Investigational Second-Generation Device Reinforces Medtronic's Commitment to Innovative Implantable Cardiac Devices Designed for Use in MRI Environment
MINNEAPOLIS, Aug 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application...
-
Jul 25, 2011Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval
MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
-
Jul 21, 2011Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall
MINNEAPOLIS, Jul 21, 2011 (BUSINESS WIRE) -- Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run the Medtronic Twin...
-
Jul 11, 2011Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon
MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...
-
Jul 8, 2011Update to July 2009 Letter to Healthcare Professionals
MINNEAPOLIS, Jul 08, 2011 (BUSINESS WIRE) -- As part of its ongoing commitment to keep patients and physicians informed about product performance and safety, Medtronic, Inc. (NYSE: MDT) is issuing...
-
Jul 7, 2011Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader...
-
Jul 7, 2011Medtronic Targets Leadership Role in Advanced Energy Surgical Technologies
MINNEAPOLIS, Jul 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire PEAK Surgical, Inc., a recognized leader in the...
-
Jul 1, 2011Europe first in line to receive Medtronic's innovative product
MEMPHIS, Tenn., Jul 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the European launch of the CD HORIZON(R) Fenestrated Screw Spinal System, which is used in conjunction...
-
Jun 30, 2011Kyphon Xpander(TM) II Inflatable Bone Tamp and the Kyphon(R) Inflation Syringe are Latest Innovation in Minimally Invasive Treatment of Spinal Fractures
MEMPHIS, Tenn., Jun 30, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the commercial release of the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation...
-
Jun 29, 2011
MINNEAPOLIS, Jun 29, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today commended the U.S. Congress and the Institute of Medicine (IOM) of the National Academy of Sciences on the release of...
-
Jun 28, 2011The CareLink(TM) Mobile Application Offers Direct Mobile Access to Data on the Medtronic CareLink(R) Network
MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of Medtronic's first mobile application for use with implantable cardiac devices. As health care...
-
Jun 28, 2011
MINNEAPOLIS, Jun 28, 2011 (BUSINESS WIRE) -- Following is a statement from Omar Ishrak, chairman and chief executive officer of Medtronic, Inc. (NYSE: MDT) on a series of articles on recombinant...
-
Jun 25, 2011STAR 3 Continuation Data, Low Glucose Suspend and Patient Reported Outcomes Highlighted at American Diabetes Association's 71st Scientific Sessions
SAN DIEGO, Jun 25, 2011 (BUSINESS WIRE) -- Research presented at the American Diabetes Association's 71st Scientific Sessions (ADA) this week adds to the clinical evidence for Medtronic's...
-
Jun 23, 2011
MINNEAPOLIS, Jun 23, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT) today approved an eight percent increase in its cash dividend for fiscal year 2012, raising the...
-
Jun 18, 2011Innovative Medical Device Shows Strong Safety and Efficacy in Treatment of Thoracic Aortic Aneurysms Through One-Year of Patient Follow-Up in U.S. Clinical Study
MINNEAPOLIS & CHICAGO, Jun 18, 2011 (BUSINESS WIRE) -- An innovative medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant(R) Thoracic Stent Graft...
-
Jun 13, 2011
Company Profile for Medtronic, Inc. Jun 13, 2011 (BUSINESS WIRE) -- Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with...
-
Jun 3, 2011
MINNEAPOLIS, Jun 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual Goldman Sachs...
-
May 24, 2011Record Fourth Quarter Revenue of $4.3 Billion Driven by Strong International Growth of 12%
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 29, 2011. Medtronic recorded fiscal...
-
May 24, 2011
MINNEAPOLIS, May 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today provided its initial revenue outlook and diluted earnings per share (EPS) guidance for fiscal year 2012. The company...
-
May 20, 2011Late-breaker at EuroPCR Confirms Low Rates of Adverse Events with Novel Heart Device in More Than 5,000 Study Subjects
PARIS, May 20, 2011 (BUSINESS WIRE) -- A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong...
-
May 20, 2011Meta-Analysis of Seven International Clinical Registries Presented at EuroPCR 2011 Late-Breaking Presentation
PARIS, May 20, 2011 (BUSINESS WIRE) -- A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the...
-
May 19, 2011New Access for Aortic Valve Replacement Achieves High Procedural Success in Italian Study of High Risk Patients
PARIS, May 19, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve(R) System,...
-
May 18, 2011Clinical Data from Multiple Studies Presented at EuroPCR Show Next-Generation Device Delivers Excellent Safety and Efficacy in Challenging Patient Population
PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...
-
May 17, 2011Two-year Results from Europe and Canada Represent Longest-term Quality-of-life Assessment of All Transcatheter Aortic Valves to Date
PARIS, May 17, 2011 (BUSINESS WIRE) -- New clinical data presented today at EuroPCR 2011 demonstrate immediate and long-term health-related quality-of-life (HRQoL) benefits for patients receiving...
-
May 16, 2011EuroPCR Program Includes Endovascular Late-Breakers on IN.PACT Drug-Eluting Balloons and Mo.Ma Ultra Embolic Protection System Enrollment in IN.PACT SFA I DEB Study Completed; PIs for IN.PACT SFA II Study Selected
MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. (NYSE: MDT) today announced...
-
May 16, 2011Kyphon(R) Xpede(TM) Bone Cement Is the Latest Offering from Medtronic for Treatment of Spinal Fractures
MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate (PMMA) bone cement for...
-
May 13, 2011
MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year end 2011 on Tuesday, May 24, 2011....
-
May 13, 2011Kyphon(R) Balloon Kyphoplasty is Among Treatments that Continue to be Covered by Major Medicare Administrative Contractor
MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that Noridian Administrative Services, a major Medicare Administrative Contractor providing Medicare...
-
May 12, 2011Highlights Include Late-Breakers and Other Scientific Sessions on CoreValve System, Resolute Drug-Eluting Stent, IN.PACT Drug-Eluting Balloons, Mo.Ma Embolic Protection System, and Renal Denervation with Symplicity Catheter System
MINNEAPOLIS, May 12, 2011 (BUSINESS WIRE) -- New clinical data on a range of innovative medical devices from Medtronic, Inc. (NYSE: MDT), to treat cardiac and vascular diseases - from severe...
-
May 10, 2011
MINNEAPOLIS, May 11, 2011 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) announced today that its board of directors named Omar Ishrak as the company's new chairman and chief executive officer,...
-
May 9, 2011
MINNEAPOLIS & TARRYTOWN, N.Y., May 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will...
-
May 5, 2011
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...
-
May 5, 2011Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society's 32nd Annual Scientific Sessions,...
-
May 5, 2011New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...
-
May 3, 2011New Feature Set Includes External AC/DC Power and Temperature Monitoring for Therapeutic Hypothermia Patients
REDMOND, Wash., May 03, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), today announced...
-
May 2, 2011New Technology Adds Diagnostic Capability to the Arctic Front(R) Cardiac CryoAblation Catheter System in Treating Paroxysmal Atrial Fibrillation
MINNEAPOLIS, May 02, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval for use, and the first patient procedure using the...
-
Apr 27, 2011Shareholders Invited to Attend Annual Meeting on Aug. 25, 2011
MINNEAPOLIS, Apr 27, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE: MDT), today announced that the company's annual meeting of shareholders will be held at 10:30 a.m.,...
-
Apr 20, 2011Artificial Disc Recipient to Raise Funds for ALS Research
MEMPHIS, Tenn., Apr 20, 2011 (BUSINESS WIRE) -- In August 2011, Doug McConnell of Barrington, Illinois, expects to be the 48th person over age 50 to successfully swim across the English Channel....
-
Apr 19, 2011Product complements Medtronic's Biologics and bone grafting portfolio
MEMPHIS, Tenn., Apr 19, 2011 (BUSINESS WIRE) -- Expanding its leading bone grafting portfolio, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the MARROWMAX(TM) Bone Marrow...
-
Apr 18, 2011New Site Offers Unrestricted Access to Interactive Learning
MINNEAPOLIS, Apr 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of its new Midas Rex e-Institute(R) website (www.e-institute.com), an enhanced web portal for...
-
Apr 11, 2011Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries
MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
-
Apr 7, 2011New Structure Uniquely Positions Medtronic to Maintain Focus on Clinicians While Addressing the Needs of Cardiac and Vascular-focused Hospital Administrators
MINNEAPOLIS, Apr 07, 2011 (BUSINESS WIRE) -- Responding to the challenges hospitals face in the changing healthcare environment, as well as the increasing importance of the hospital administrator...
-
Apr 4, 2011Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers
NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
-
Apr 4, 2011Software Helps Users Identify Low and High Glucose Levels
MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink(R) Personal 5.4 Therapy Management...
-
Apr 4, 2011Study Published Today in Circulation is the First to Assess the Correlation of Seven Heart Failure Process-Based Quality Measures with Clinical Outcomes
MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE:...
-
Apr 1, 2011Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence
MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...
-
Mar 28, 2011Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission
MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced the imminent release of the pivotal U.S. data on its Resolute(R) drug-eluting stent (DES) at ACC.11, the 60th
-
Mar 28, 2011New Implantable Cardiac Devices with SmartShock(TM) Technology Enhance Patient Quality of Life
MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta(TM)portfolio of implantable...
-
Mar 24, 2011CRT Innovation is the First to Offer Exclusive OptiVol(R) Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management
MINNEAPOLIS, Mar 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food & Drug Administration (FDA) has approved its Consulta(R) and Syncra(TM) cardiac...
-
Mar 16, 2011Single-Channel Device Completes Medtronic's Advanced Activa(R) Therapy Portfolio for Patients with Movement Disorders
MINNEAPOLIS, Mar 16, 2011 (BUSINESS WIRE) -- With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation (DBS) therapy, Medtronic, Inc. (NYSE: MDT) today announced...
-
Mar 14, 2011NewRemodeling Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio
MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour...
-
Mar 14, 2011
MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it is pledging a total of $1 million (U.S.) in direct grants, employee matching grants and product...
-
Mar 11, 2011
MINNEAPOLIS, Mar 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Barclays Capital 2011...
-
Mar 10, 2011Offering Surgeons A New Plate Design To Treat The Cervical Spine
MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the ATLANTIS...
-
Mar 10, 2011
MINNEAPOLIS, Mar 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $500 million of its 2.625% Senior Notes due 2016 and $500 million of its 4.125%...
-
Mar 10, 2011Offering Surgeons An Additional Rod Material Option To Treat The Occipitocervical and Upper-Thoracic Spine
MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of VERTEX...
-
Mar 9, 2011
MINNEAPOLIS, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning...
-
Mar 9, 2011Facility established to meet the increase in demand for high quality cardiac devices in Asia
SINGAPORE, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore...
-
Mar 8, 2011CONNECT Trial Demonstrates Clinical and Economic Benefits of Remote Monitoring in Reducing Hospital Stays and In-Office Visits for Cardiac Patients Treated with Implantable Devices
MINNEAPOLIS, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from a clinical trial that showed remote monitoring of implantable cardiac device patients with the...
-
Mar 8, 2011Facility established to support further localization in the region
SHANGHAI, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new regional headquarters building in Shanghai, China....
-
Mar 4, 2011Innovative Technology Designed to Optimize Arctic Front(R) Cardiac CryoAblation Catheter System in the Treatment of Paroxysmal Atrial Fibrillation
MINNEAPOLIS & TOLOCHENAZ, Switzerland, Mar 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the European launch of the Achieve(TM) Mapping Catheter, an intra-cardiac...
-
Mar 3, 2011Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS
MINNEAPOLIS, Feb 03, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
-
Mar 3, 2011HeartRescue Project is first multi-state effort to systemically tackle one of nation's leading killers
MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- The Medtronic Foundation announced today a $15 million commitment to reduce sudden cardiac arrest deaths in the United States. The HeartRescue Project...
-
Mar 3, 2011"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the sixth...
-
Mar 2, 2011
MINNEAPOLIS, Mar 02, 2011 (BUSINESS WIRE) -- In its continued commitment to reduce the global burden of non-communicable diseases (NCDs), Medtronic, Inc. today announced it will make nearly $4...
-
Feb 28, 2011
MINNEAPOLIS, Feb 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that its Mosaic(R) bioprosthetic heart valve has demonstrated positive performance results at 12 years in a...
-
Feb 25, 2011
MINNEAPOLIS, Feb 25, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research &...
-
Feb 24, 2011
MINNEAPOLIS, Feb 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Citi 2011 Global...
-
Feb 20, 2011Revenue of $4.0 Billion Grew 3% on Strength of New Products
MINNEAPOLIS, Feb 22, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2011, which ended January 28, 2011. The company...
-
Feb 18, 2011CoreValve Italian Registry Results Demonstrate Clinical Benefits in a Real-World Patient Population
MINNEAPOLIS, Feb 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today issued a statement on results from an independent study published online in the journal Circulation, which confirmed...
-
Feb 17, 2011Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows
MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT), announced today thattwo-year data from the largest multicenter randomized controlled study of Kyphon Balloon Kyphoplasty...
-
Feb 17, 2011Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows
MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TWO-YEAR STUDY CONTINUES TO...
-
Feb 17, 2011
MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
-
Feb 16, 2011
MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the corrections being made to product...
-
Feb 16, 2011Study Showed Minimally Invasive Procedure Provided Better Back Function, More Rapid Back Pain Relief and Improved Quality of Life Compared with Non-surgical Care
MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with...
-
Feb 14, 2011
MINNEAPOLIS, Feb 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2011 on Tuesday, February 22,...
-
Feb 9, 2011Companies to launch RhinoChill Intranasal Cooling System in Europe and jointly develop future potential solutions
REDMOND, Wash. & SAN DIEGO, Feb 09, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT) and...
-
Feb 9, 2011
MEMPHIS, Tenn., Feb 09, 2011 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that the United States Court of Appeals for the Federal Circuit affirmed that the Pivot system offered by...
-
Feb 8, 2011Revo MRI(TM) SureScan(R) Pacing System Offers Pacemaker Patients Access to MRI Scans
MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI(TM) SureScan(R) pacing system, the...
-
Feb 8, 2011
MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. District Court of Delaware issued its ruling on post-trial motions filed by the parties in...
-
Feb 4, 2011Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS
MINNEAPOLIS, Feb 04, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
-
Jan 27, 2011Latest innovation in technology offers new capabilities for surgeons, hospitals and their patients
MEMPHIS, Tenn., Jan 27, 2011 (BUSINESS WIRE) -- Continuing a stream of recent advancements for stabilization of the spine, Medtronic, Inc. (NYSE: MDT) today announced both the release of its CD...
-
Jan 18, 2011Inoperable Patients Will Be Evaluated in Single Arm Study, Not Randomized to Medical Management
MINNEAPOLIS, Jan 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to modify its...
-
Jan 13, 2011Interventional Therapy Addresses Uncontrolled Hypertension with Renal Denervation
MINNEAPOLIS & MOUNTAIN VIEW, Calif., Jan 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced that it has completed the acquisition of privately-held Ardian, Inc., a developer...
-
Jan 7, 2011
MINNEAPOLIS, Jan 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 29th annual J.P. Morgan...
-
Jan 5, 2011Grants to Partners In Health and International Medical Corps fulfill commitment made following the 2010 earthquake
MINNEAPOLIS, Jan 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today $750,000 in grants through the Medtronic Foundation to support continued healthcare infrastructure...
-
Jan 3, 2011
MINNEAPOLIS, Jan 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Goldman Sachs Healthcare CEOs...
-
Dec 21, 2010Endurant(R) AAA Stent Graft Expands Patient Access to Minimally Invasive Procedure To Repair Dangerous Bulge in Body's Main Artery Without Major Surgery
MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- An estimated 1.2 million people in the United States have an abdominal aortic aneurysm (AAA) - a dangerous bulge or ballooning in their bodies' main...
-
Dec 21, 2010Investigational Therapy Offers Treatment Alternative to Open Heart-Surgery for Patients with Severe Aortic Stenosis
MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the beginning of its Medtronic CoreValve(R) U.S. Pivotal clinical trial in the United States. The first...